NEWPORT PHARMACEUTICALS <NWPH> 3RD QTR LOSS Period ended January 31. Shr loss six cts vs profit one ct Net loss 536,000 vs profit 166,000 Revs 2,099,000 vs 3,149,000 Avg shrs 10,429,000 vs 9,943,000 Nine Mths Shre loss nine cts vs loss five cts Net loss 790,000 vs loss 377,000 Revs 7,089,000 vs 7,646,000 Avg shrs 10,406,000 vs 9,351,000 Note: Full name Newport Pharmaceuticals International Inc.